Lyophilized Injectable Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Lyophilized Injectable Drugs Market - Overview
This report analyzes the current and future scenario of the global lyophilized injectable drugs market. Lyophilization is a freeze drying process used for the removal of water from the final product. In lyophilization, output products are frozen under high vacuum. The lyophilization process is used in the biotechnological and pharmaceutical manufacturing industries for the production of good quality products with expanded lifespan. The global lyophilized injectable drugs market is driven by rise in chronic health conditions, increase in geriatric and overall population with cardiac and neurological defects, expansion of pipeline of lyophilized injectable drugs, reduced risk of administration of lyophilized injectable drugs with prefilled diluent syringes, and technological advancements. Moreover, lyophilization enables safe transit and storage of these substances until their end use. Rise in quality concerns has made lyophilization of injectable drugs quite essential. Lyophilized injectable drugs have proven to be safer and effective to administer after storing for a long period than other dried products. This is expected to drive the global lyophilized injectable drugs market during the forecast period.
The global lyophilized injectable drugs market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on type of packaging, type of delivery, indication, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global lyophilized injectable drugs market.
Global Lyophilized Injectable Drugs Market: Key Segments
In terms of type of packaging, the global market has been segmented into single-use vials, point-of-care reconstitution, specialty packaging, and others. Based on type of delivery, the market has been classified into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. Based on indication, the global lyophilized injectable drugs market has been categorized into autoimmune diseases, infectious diseases, metabolic conditions, and others. In terms of end-user, the market has been divided into hospitals, ambulatory surgical centers, specialty clinics, and others. The market size and forecast for each of these segments have been provided in terms of US$ Mn for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Lyophilized Injectable Drugs Market: Regional Outlook
Geographically, the global lyophilized injectable drugs market has been segmented into five major regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global lyophilized injectable drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players in the global market are B. Braun Melsungen AG, Baxter, Becton, Dickinson and Company, Mylan N.V., Schott AG, SHL Group, Vetter Pharma, CIRON Drugs & Pharmaceuticals Pvt. Ltd, and Jubilant HollisterStier.
The global lyophilized injectable drugs market has been segmented as below:
Global Lyophilized Injectable Drugs Market, by Type of Packaging
Global Lyophilized Injectable Drugs Market, by Type of Delivery
Prefilled Diluent Syringes
Proprietary Reconstitution Devices
Global Lyophilized Injectable Drugs Market, by Indication
Global Lyophilized Injectable Drugs Market, by End-user
Ambulatory Surgical Centers
Global Lyophilized Injectable Drugs Market, by Region
Rest of Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.